EU-funded project named `MICROBE DIAGNOSTICS` has developed new tools that enable more extensive and rapid analysis of our gut microbiota than has been possible earlier.
These new methods are based on the unique genetical codes each microbe contains. The project has developed 16 new testing devices, so called oligonucleotide probes. These probes are able to describe a more varied set of organisms that live in our microbiota than previously has been recognised by scientific methods. With these methods, researchers in the project have found previously unfamiliar bacteria present in the human gastrointestinal tract. A further improvement in this methodology is applying flow cytometry, which can rapidly analyse a large number of samples reliably.
The reason for developing these new tools is that we still have relatively little information about the variety of different organisms that live in our microbiota. There seems to be great variety among people, but what is the significance of this variation is not yet known. Also the used methods have been slow to apply. This lack of basic understanding is an obstacle if we want to modify the microbiota and increase the amount of beneficial microbes and find relationships between gut microbiota and diseases. Learning to know what the microbes are is not enough, however. In addition, we have to further learn what is their function in the body. The new knowledge can be used to identify the components of normal gut microbiota that may play a part in onset of inflammatory bowel disease (IBD). With this enhanced knowledge we may be able to prevent the disease or improve its treatment with beneficial probiotic microbes.
Prof. Dr. Michael Blaut | alfa
Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH
Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences